Blockchain Registration Transaction Record

Nutriband CEO Discusses AVERSA(TM) Platform in BioMedWire Podcast

Nutriband CEO Gareth Sheridan discusses the company's AVERSA(TM) platform in The BioMedWire Podcast, offering insights into transdermal drug delivery systems and pain management. Learn how Nutriband aims to improve safety and accessibility in the fentanyl patch market.

Nutriband CEO Discusses AVERSA(TM) Platform in BioMedWire Podcast

This news matters as it sheds light on Nutriband's innovative solution to the opioid crisis in pain management. The development of AVERSA(TM) showcases the company's commitment to addressing the challenges faced by pain patients and the healthcare industry as a whole.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x518670d9da52091444b94338cb7d0232874db0dd506e4fc7868dbce6f0fe4616
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintsage8e2k-3d38e364ed46752a3bb0911d6476c414